ID   ICC13-7
AC   CVCL_A1VD
SY   ICC137
DR   cancercelllines; CVCL_A1VD
DR   DepMap; ACH-001839
DR   Wikidata; Q105509595
RX   PubMed=31109923;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3689; FGFR2 + HGNC; HGNC:17142; OPTN; Name(s)=FGFR2-OPTN; Note=In frame. FGFR2 exon 17 fused to OPTN exon 9 (PubMed=31109923).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): DepMap=ACH-001839
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 11
ST   D18S51: 13,14
ST   D21S11: 32.2
ST   D3S1358: 18
ST   D5S818: 10,11
ST   D7S820: 8,9
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 5,7
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 15,18
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
RX   PubMed=31109923; DOI=10.1158/2159-8290.CD-19-0182; PMCID=PMC6677584;
RA   Goyal L., Shi L., Liu L.Y., Fece de la Cruz F., Lennerz J.K.,
RA   Raghavan S., Leschiner I., Elagina L., Siravegna G., Ng R.W.S., Vu P.,
RA   Patra K.C., Saha S.K., Uppot R.N., Arellano R.S., Reyes S., Sagara T.,
RA   Otsuki S., Nadres B., Shahzade H.A., Dey-Guha I., Fetter I.J., Baiev I.,
RA   Van Seventer E.E., Murphy J.E., Ferrone C.R., Tanabe K.K., Deshpande V.,
RA   Harding J.J., Yaeger R.D., Kelley R.K., Bardelli A., Iafrate A.J.,
RA   Hahn W.C., Benes C.H., Ting D.T., Hirai H., Getz G., Juric D.,
RA   Zhu A.X.-X., Corcoran R.B., Bardeesy N.M.;
RT   "TAS-120 overcomes resistance to ATP-competitive FGFR inhibitors in
RT   patients with FGFR2 fusion-positive intrahepatic cholangiocarcinoma.";
RL   Cancer Discov. 9:1064-1079(2019).
//
RX   PubMed=39026794; DOI=10.1101/2024.07.04.601970; PMCID=PMC11257448;
RA   Vijay V., Karisani N., Shi L., Hung Y.-H., Vu P., Kattel P., Kenney L.,
RA   Merritt J., Adil R., Wu Q.-B., Zhen Y.-L., Morris R., Kreuzer J.,
RA   Kathiresan M., Herrera Lopez X.I., Ellis H., Gritti I.G., Lecorgne L.,
RA   Farag I., Popa A., Shen W., Kato H., Xu Q., Balasooriya E.R., Wu M.-J.,
RA   Chaturantabut S., Kelley R.K., Cleary J.M., Lawrence M.S., Root D.E.,
RA   Benes C.H., Deshpande V., Juric D., Sellers W.R., Ferrone C.R., Haas W.,
RA   Vazquez F., Getz G., Bardeesy N.M.;
RT   "Generation of a biliary tract cancer cell line atlas reveals
RT   molecular subtypes and therapeutic targets.";
RL   bioRxiv 2024:07.04.601970-07.04.601970(2024).
//